Sleep, Wake and Light Therapy for Depression
Primary Purpose
Depression, Depressive Disorder, Major, Depression, Unipolar
Status
Completed
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Wake and Light Therapy
Sleep and Light Therapy
Sponsored by
About this trial
This is an interventional treatment trial for Depression focused on measuring Circadian Rhythm, Light Therapy, Wake Therapy, Sleep Phase Advance, Major Depression
Eligibility Criteria
Inclusion Criteria:
- Diagnosis of Depressive Episode (ICD10 F32) or Recurrent Depressive Disorder (F33).
- Minimum score of 8 or more on the Hamilton Depression Rating Scale (6 item) (Range 0-22) (Bech,1981).
- Age 18-65
- Able to give informed consent
- Women of child bearing age may be included and no methods of contraception is required to enable inclusion into the trial.
Exclusion Criteria:
- Current diagnosis of Seasonal Affective Disorder
- Current diagnosis of anorexia nervosa or bulimia.
- Current diagnosis of an obsessive compulsive or related disorder
- Current diagnosis of post-traumatic stress disorder
- History of schizophrenia, schizoaffective disorder or bipolar disorder
- Severe cognitive impairment, dementia, intellectual disability or organic brain disorder.
- History of stimulant or hallucinogenic misuse, alcohol or substance misuse or dependence in past 3 months.
- Borderline Personality Disorder or other personality disorder considered to be the main problem.
- Duration of depression more than 2 years.
- Significant risk of suicide that requires hospitalisation.
- Severe eye disease or cataracts or traumatic injury or visual impairment affecting both eyes.
- History of epilepsy, uncontrolled severe headaches, or stroke as this may lower seizure threshold through sleep deprivation.
- Unstable medical condition that would make wake therapy intolerable
- Untreated sleep disorder such as obstructive sleep apnoea or narcolepsy
- Use of photo-sensitizing drugs.
- Current night-shift work.
- Non-English speaker.
Sites / Locations
- South London and Maudsley NHS Foundation Trust
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Wake and Light Therapy
Sleep and Light Therapy
Arm Description
This consists of (a) Total Sleep Deprivation with group support on days one and two; (b) Phase Advance of Sleep over 5 days and daily Light Therapy. (c) Light Therapy is given daily
Participants will be given information on sleep hygiene and getting a good night's sleep. They are then given Light Therapy daily for 1 week.
Outcomes
Primary Outcome Measures
Number of participants recruited per month/Adherence to the protocol
To compare the rate of recruitment and adherence to the treatments in both groups
Secondary Outcome Measures
MINI International Neuropsychiatric Interview Version 5.0
To determine diagnosis by DSM-IV criteria
Hamilton Depression Rating Scale
To compare the effects on observer rated depressive symptoms in both groups
Clinical Global Impression and Improvement Scale (Guy, 1976)
To compare the effects on observer rated clinical impression in both groups
Quick Inventory of Depressive Symptomatology -SR Version (Triveni et al., 2004) Questionnaire
To compare the effects on subjective depressive symptoms in both groups
Brief Ruminative Response Scale (Topper et al, 2014). Questionnaire
To compare the effects on measures of subjective rumination in both groups
Pittsburgh Sleep Index (Bysse et al., 1999) Questionnaire
To compare the effects on subjective sleep quality in both groups
Euroquol 5D (1990) Questionnaire
To compare the effects on subjective general quality of life in both groups
To check the amount of current antidepressant use
Amount of antidepressant drugs (in mg of antidepressant equivalents) (Hayasaka et al., 2015) or benzodiazepine drugs (in mg of diazepam equivalents)
To check the amount of current psychotherapy use
The amount of Cognitive Behaviour Therapy or any other counselling or psychotherapy (number of hours)
Daily sleep diary
A subjective measure of total sleep time
Credibility and Expectancy Questionnaire (Devilly, 2000).
A measure of the credibility of the intervention
Morning/Evening Questionnaire
A measure of morning/evening preference
Wrist actigraph from GeneActiv daily (Physiological parameter)
A measure of the sleep/wake activity, which correlates with the gold standard of sleep physiology (polysomnography).
Full Information
NCT ID
NCT03405493
First Posted
January 5, 2018
Last Updated
September 25, 2019
Sponsor
King's College London
Collaborators
Kings Health Partners
1. Study Identification
Unique Protocol Identification Number
NCT03405493
Brief Title
Sleep, Wake and Light Therapy for Depression
Official Title
Sleep, Wake and Light Therapy for Depression
Study Type
Interventional
2. Study Status
Record Verification Date
January 2019
Overall Recruitment Status
Completed
Study Start Date
January 18, 2018 (Actual)
Primary Completion Date
September 23, 2019 (Actual)
Study Completion Date
September 23, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
King's College London
Collaborators
Kings Health Partners
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The aim of this study is to determine if altering the pattern of one's sleep and having light therapy can speed up the treatment of depression. In the UK, the large majority of patients with depression in the NHS are treated in the community, and one of the major objectives of the study one is to determine if this therapy is a practical treatment in the community. We will be comparing two treatments:
Sleep Therapy and a Light Box: Participants will be given information and advice on how to get a good night's sleep. Participants will be given a light box to use in the morning for 1 week. Treatment with a light box will last 30 minutes when a person gets up. Participants may continue to have any treatment as usual (for example medication or talking therapies).
Wake therapy and a Light Box: Participants will be helped to change the pattern of sleep by depriving participants of sleep for one night. Participants will go bed at 5pm on the following day for 8 hours and get up at 1am. Participants' sleep will then be advanced by 2 hours each night for the next three nights. Participants will be also given a light box to use in the morning for 1 week. Treatment with a light box will last 30 minutes when participants get up. Participants may continue to have any treatment as usual (for example medication or talking therapies).
Detailed Description
Participants will be given a wristband (Actigraph)
Participants will be asked to complete various questionnaires and be interviewed at 1 week, 2 weeks, 4 weeks, 8 weeks and at 6 months after starting.
Participants will be asked to make 6 extra visits to the research team at the hospital over and above those needed for normal care.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Depression, Depressive Disorder, Major, Depression, Unipolar, Depression Moderate
Keywords
Circadian Rhythm, Light Therapy, Wake Therapy, Sleep Phase Advance, Major Depression
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Both groups will receive treatment as usual.
Triple Chronotherapy. This consists of (a) Total Sleep Deprivation with group support on days one and two; (b) Phase Advance of Sleep over 5 days and daily Light Therapy. (c) Bright Light Therapy is given on Day 2 onwards daily.
Comparator Intervention: Participants will be given information on sleep hygiene and getting a good night's sleep in a written leaflet and given the opportunity to ask questions. They are then given Dim Amber Light Therapy daily for 1 week.
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
60 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Wake and Light Therapy
Arm Type
Experimental
Arm Description
This consists of (a) Total Sleep Deprivation with group support on days one and two; (b) Phase Advance of Sleep over 5 days and daily Light Therapy. (c) Light Therapy is given daily
Arm Title
Sleep and Light Therapy
Arm Type
Active Comparator
Arm Description
Participants will be given information on sleep hygiene and getting a good night's sleep. They are then given Light Therapy daily for 1 week.
Intervention Type
Behavioral
Intervention Name(s)
Wake and Light Therapy
Intervention Description
Participants will be helped to change the pattern sleep by depriving participants of sleep for one night. On Day 1 participants will be supported to stay up all night and the following day at the Hospital. Participants can go to bed by 5pm at home on Day 2. Participants will need to get up by about 1am and return to the hospital to be supported to stay awake. Participants will then go to bed at 7pm on Day 3. Participants will be asked to sleep until 3am and then stay awake at home until bed at 9pm on Day 4. Participants will then get up by 5am on Day 5 and stay awake until 11pm to resume a normal sleep routine waking by 7am on Day 6. Participants will also be given a light box to use each morning. For the light box, participants will be asked to sit about one foot away from a light box. You will be free to have breakfast, read or use a computer while facing towards the light. Treatment with a light box will last 30 minutes. Participants may continue to have treatment as usual.
Intervention Type
Behavioral
Intervention Name(s)
Sleep and Light Therapy
Intervention Description
Participants will be given information and advice on how to get a good night's sleep. Participants will be also given a light box to use in the morning for 1 week. For the light box, participants will be asked to sit about one foot away from a light box. Participants will be free to have breakfast, read or use a computer while facing towards the light. Treatment with a light box will last 30 minutes when you get up. Participants may continue to have any treatment as usual (for example medication or talking therapies).
Primary Outcome Measure Information:
Title
Number of participants recruited per month/Adherence to the protocol
Description
To compare the rate of recruitment and adherence to the treatments in both groups
Time Frame
Week 1
Secondary Outcome Measure Information:
Title
MINI International Neuropsychiatric Interview Version 5.0
Description
To determine diagnosis by DSM-IV criteria
Time Frame
Baseline
Title
Hamilton Depression Rating Scale
Description
To compare the effects on observer rated depressive symptoms in both groups
Time Frame
Baseline, and at 1, 2, 4, 8 weeks and 6-month post-randomisation
Title
Clinical Global Impression and Improvement Scale (Guy, 1976)
Description
To compare the effects on observer rated clinical impression in both groups
Time Frame
Baseline, and at 1, 2, 4, 8 weeks and 6-month post-randomisation
Title
Quick Inventory of Depressive Symptomatology -SR Version (Triveni et al., 2004) Questionnaire
Description
To compare the effects on subjective depressive symptoms in both groups
Time Frame
Baseline, and at 1, 2, 4, 8 weeks and 6-month post-randomisation
Title
Brief Ruminative Response Scale (Topper et al, 2014). Questionnaire
Description
To compare the effects on measures of subjective rumination in both groups
Time Frame
Baseline, and at 1, 2, 4, 8 weeks and 6-month post-randomisation
Title
Pittsburgh Sleep Index (Bysse et al., 1999) Questionnaire
Description
To compare the effects on subjective sleep quality in both groups
Time Frame
Baseline, and at 1, 2, 4, 8 weeks and 6-month post-randomisation
Title
Euroquol 5D (1990) Questionnaire
Description
To compare the effects on subjective general quality of life in both groups
Time Frame
Baseline, and at 1, 2, 4, 8 weeks and 6-month post-randomisation
Title
To check the amount of current antidepressant use
Description
Amount of antidepressant drugs (in mg of antidepressant equivalents) (Hayasaka et al., 2015) or benzodiazepine drugs (in mg of diazepam equivalents)
Time Frame
Baseline, and at 1, 2, 4, 8 weeks and 6-month post-randomisation
Title
To check the amount of current psychotherapy use
Description
The amount of Cognitive Behaviour Therapy or any other counselling or psychotherapy (number of hours)
Time Frame
Baseline, and at 1, 2, 4, 8 weeks and 6-month post-randomisation
Title
Daily sleep diary
Description
A subjective measure of total sleep time
Time Frame
3 days pre-randomisation and 7 days post-randomisation
Title
Credibility and Expectancy Questionnaire (Devilly, 2000).
Description
A measure of the credibility of the intervention
Time Frame
Baseline
Title
Morning/Evening Questionnaire
Description
A measure of morning/evening preference
Time Frame
3 days pre-randomisation
Title
Wrist actigraph from GeneActiv daily (Physiological parameter)
Description
A measure of the sleep/wake activity, which correlates with the gold standard of sleep physiology (polysomnography).
Time Frame
3 days pre-randomisation and 7 days post-randomisation.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Diagnosis of Depressive Episode (ICD10 F32) or Recurrent Depressive Disorder (F33).
Minimum score of 8 or more on the Hamilton Depression Rating Scale (6 item) (Range 0-22) (Bech,1981).
Age 18-65
Able to give informed consent
Women of child bearing age may be included and no methods of contraception is required to enable inclusion into the trial.
Exclusion Criteria:
Current diagnosis of Seasonal Affective Disorder
Current diagnosis of anorexia nervosa or bulimia.
Current diagnosis of an obsessive compulsive or related disorder
Current diagnosis of post-traumatic stress disorder
History of schizophrenia, schizoaffective disorder or bipolar disorder
Severe cognitive impairment, dementia, intellectual disability or organic brain disorder.
History of stimulant or hallucinogenic misuse, alcohol or substance misuse or dependence in past 3 months.
Borderline Personality Disorder or other personality disorder considered to be the main problem.
Duration of depression more than 2 years.
Significant risk of suicide that requires hospitalisation.
Severe eye disease or cataracts or traumatic injury or visual impairment affecting both eyes.
History of epilepsy, uncontrolled severe headaches, or stroke as this may lower seizure threshold through sleep deprivation.
Unstable medical condition that would make wake therapy intolerable
Untreated sleep disorder such as obstructive sleep apnoea or narcolepsy
Use of photo-sensitizing drugs.
Current night-shift work.
Non-English speaker.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
David Veale
Organizational Affiliation
King's College London
Official's Role
Principal Investigator
Facility Information:
Facility Name
South London and Maudsley NHS Foundation Trust
City
London
Country
United Kingdom
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Learn more about this trial
Sleep, Wake and Light Therapy for Depression
We'll reach out to this number within 24 hrs